Sharon, China

Wenda Gao

This inventor holds 1 USPTO granted patent. Top assignee: Beth Israel Deaconess Medical Center, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wenda Gao. Retrieved from https://idiyas.com/inventor/wenda-gao-dftv0fm9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wenda Gao: Innovator in T-Cell Research

Introduction

Wenda Gao is a notable inventor based in Sharon, China. She has made significant contributions to the field of immunology, particularly in the area of T-cell function and exhaustion. Her innovative work has the potential to impact therapeutic strategies for various diseases.

Latest Patents

Wenda Gao holds a patent titled "Compositions and Methods for Preventing or Reversing T-Cell Exhaustion Through Ectonucleotidase Inhibition and Antibody-Mediated Target Cytosis." This patent reflects her research focus on enhancing T-cell responses, which is crucial for improving immune therapies.

Career Highlights

Wenda Gao is affiliated with Beth Israel Deaconess Medical Center, Inc., where she conducts her research. Her work has garnered attention for its potential applications in treating immune-related conditions. With 1 patent to her name, she is recognized for her innovative contributions to the scientific community.

Collaborations

Wenda has collaborated with esteemed colleagues, including Simon C. Robson and Yan Wu Shang. These partnerships have enriched her research and expanded the impact of her findings in the field.

Conclusion

Wenda Gao is a pioneering inventor whose work in T-cell research is paving the way for advancements in immunotherapy. Her contributions are vital to the ongoing efforts to enhance immune responses and develop new treatment strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…